{
    "2019-11-06": [
        [
            {
                "time": "",
                "original_text": "A股将迎史上最大外资扩容 谁会成为最大受益者？",
                "features": {
                    "keywords": [
                        "A股",
                        "外资扩容",
                        "受益者"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "外资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【西部医药吴文华】大参林深度报告：省内精耕省外加速，盈利进入良性循环",
                "features": {
                    "keywords": [
                        "大参林",
                        "省内精耕",
                        "省外加速",
                        "良性循环"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信建投评医药三季报：医药外包、器械景气度上行",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药三季报",
                        "医药外包",
                        "器械",
                        "景气度上行"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信建投十二大研究团队复盘三季报",
                "features": {
                    "keywords": [
                        "中信建投",
                        "研究团队",
                        "三季报",
                        "复盘"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}